SDC1 and hepatocellular carcinoma: Consistent with this, among patients with alcoholic cirrhosis, high serum syndecan-1 levels were significantly associated with a greater risk of tumor recurrence in patients with early HCC treated with RFA, as well as with less favorable overall survival [21].